RxDoctor Payments Data

Edward Tribuzio, MD

Family Medicine · Fernandina Beach, FLNPI 1174501571

Payments from drug & device makers

$11,173in general payments, 2019–2025

Across 649 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • Lilly USA, LLC$1K
  • AstraZeneca$778
  • GSK$638
  • Boehringer Ingelheim$612
  • plus $5K from 53 others

What the payments were for

  • Food & beverage$11,06599%
  • Education$1081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk97$1,401
AbbVie(2 entities)85$1,218
Lilly USA, LLC72$1,048
AstraZeneca49$778
GSK37$638
Boehringer Ingelheim26$612
Pfizer38$527
Astellas Pharma US Inc14$330
Boston Scientific4$305
Sanofi-aventis U.S. LLC15$301
Antares Pharma, Inc.13$256
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$251
Takeda Pharmaceuticals U.S.A., Inc.16$242
Bayer12$225
Novartis14$224
Amgen13$209
Biohaven Pharmaceuticals, Inc.7$207
Amarin Pharma, Inc.9$169
Painteq LLC2$150
Johnson & Johnson3$148
Dexcom, Inc.3$132
Abbott8$127
Exact Sciences8$118
Teva Pharmaceuticals USA, Inc.7$114
Phathom Pharmaceuticals, Inc.5$112
Biohaven Pharmaceutical Holding Company Ltd.4$107
Sunovion Pharmaceuticals Inc.9$102
Kowa Pharmaceuticals America, Inc.6$98
Xeris Pharmaceuticals, Inc.4$89
Idorsia Pharmaceuticals US Inc4$64
Merck4$64
Alnylam Pharmaceuticals Inc.3$58
Aimmune Therapeutics, Inc.3$50
Genentech USA, Inc.2$46
Radius Health, Inc.1$44
Clarus Therapeutics Inc.3$42
E.r. Squibb & Sons, L.L.C.2$41
Upsher-smith Laboratories LLC2$41
Eisai Inc.2$40
Sanofi Pasteur Inc.2$37
Avanir Pharmaceuticals, Inc.2$36
Sumitomo Pharma America, Inc.2$35
Nestle Healthcare Nutrition Inc.2$35
Halozyme Inc2$31
Inogen, Inc.1$30
Acerus Pharmaceuticals Corporation2$27
Endo Pharmaceuticals Inc.2$27
Supernus Pharmaceuticals, Inc.1$25
Arbor Pharmaceuticals, Inc.1$19
Lundbeck LLC1$18
Collegium Pharmaceutical, Inc.1$17
Biogen1$16
Daiichi Sankyo Inc.1$16
Hologic Sales And Service, LLC1$16
Jazz Pharmaceuticals Inc.1$16
Otsuka America Pharmaceutical, Inc.1$14
Aytu Biopharma, Inc.1$14
Zyla Life Sciences, Inc.1$12
Cvrx, Inc.1$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,173 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$539,934
Medicare patients
1,192
Services billed
18,365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban327$177,104
OzempicSemaglutide106$133,304
JardianceEmpagliflozin136$84,689
TrulicityDulaglutide57$65,975
MounjaroTirzepatide44$52,832
EntrestoSacubitril/Valsartan70$43,890
XareltoRivaroxaban51$36,783
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen989$32,852
AptiomEslicarbazepine Acetate11$29,936
Breztri AerosphereBudesonide/Glycopyr/Formoterol37$27,831
Tresiba Flextouch U-200Insulin Degludec30$24,754
Tresiba Flextouch U-100Insulin Degludec43$22,629
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$21,751
FarxigaDapagliflozin Propanediol22$20,950
MyrbetriqMirabegron34$20,556

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$527$177,104327 claims
Novo NordiskOzempic$1,401$133,304106 claims
Lilly USA, LLCTrulicity, Mounjaro$1,048$118,806101 claims
Boehringer IngelheimJardiance$612$84,689136 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$778$54,70978 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$638$45,04693 claims
NovartisEntresto$224$43,89070 claims
Johnson & JohnsonXarelto$148$36,78351 claims
Sunovion Pharmaceuticals Inc.Aptiom$102$29,93611 claims
MerckJanuvia, Verquvo$64$21,72244 claims
Astellas Pharma US IncMyrbetriq$330$20,55634 claims
AbbVieLinzess$1,218$19,95122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Fernandina Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →